Safety Study of AMG 557 in Subjects With Lupus Arthritis
NCT01683695
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Lupus Arthritis, Systemic Lupus Erythematosus
Interventions
DRUG:
AMG 557
DRUG:
Matching Placebo
Sponsor
Amgen